Home › Research › Health systems and care delivery
Characteristics of Parkinson’s Disease in Patients with and without Cognitive Impairment
Julie M. Chandler, Radhika Nair, Kevin Biglan, Erin A. Ferries, Leanne M. Munsie, Tich Changamire, Nick C. Patel. Journal of Parkinson s Disease, 2021-03-12
Topic: Risk, prevention and care in population studies
Plain-language summary
Comorbidity indices for patients with cognitive impairment increased during the 6-year study period, especially after the index. Enrollment in Medicare Advantage Prescription Drug plans vs. commercial (OR = 1.60), dual Medicare/Medicaid eligibility (OR = 1.36), cerebrovascular disease (OR = 1.24), and PD medication use (OR = 1.46) were associated with a new cognitive impairment diagnosis (all p < 0.05). A greater proportion of patients with cognitive impairment had hospitalizations and emergency department visits and higher median total healthcare costs than controls for each year pre- and post-index. In patients with PD newly diagnosed with cognitive impairment, comorbidity burden, hospitalizations, emergency department visits, and total costs peaked 1-year pre- and post-identification. These data coupled with recommendations for annual screening for cognitive impairment in PD support the early diagnosis and management of cognitive impairment in order to optimize care for patients and their caregivers.
What this study adds
Evidence grade: Low
The record lists 2,711 participants. This study describes characteristics of patients with Parkinson's disease who were newly diagnosed with cognitive impairment, including more hospitalizations and higher healthcare costs. Reported effect size: OR = 1.60; OR = 1.36; OR = 1.24.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Chandler, J. M., Nair, R., Biglan, K., Ferries, E. A., Munsie, L. M., Changamire, T., et al. (2021). Characteristics of Parkinson’s Disease in Patients with and without Cognitive Impairment. Journal of Parkinson s Disease. https://doi.org/10.3233/jpd-202190
Vancouver
Chandler JM, Nair R, Biglan K, Ferries EA, Munsie LM, Changamire T, et al. Characteristics of Parkinson’s Disease in Patients with and without Cognitive Impairment. Journal of Parkinson s Disease. 2021. doi:10.3233/jpd-202190. PMID: 33720850.
BibTeX
@article{chandler2021-33720850,
author = {Chandler, Julie M. and Nair, Radhika and Biglan, Kevin and Ferries, Erin A. and Munsie, Leanne M. and Changamire, Tich and Patel, Nick C.},
title = {{Characteristics of Parkinson’s Disease in Patients with and without Cognitive Impairment}},
journal = {Journal of Parkinson s Disease},
year = {2021},
doi = {10.3233/jpd-202190},
pmid = {33720850},
url = {https://doi.org/10.3233/jpd-202190}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Comorbidity indices for patients with cognitive impairment increased during the 6-year study period, especially after the index.
- Enrollment in Medicare Advantage Prescription Drug plans vs. commercial (OR = 1.60), dual Medicare/Medicaid eligibility (OR = 1.36), cerebrovascular disease (OR = 1.24), and PD medication use (OR = 1.46) were associated with a new cognitive impairment diagnosis (all p < 0.05).
- A greater proportion of patients with cognitive impairment had hospitalizations and emergency department visits and higher median total healthcare costs than controls for each year pre- and post-index.
- In patients with PD newly diagnosed with cognitive impairment, comorbidity burden, hospitalizations, emergency department visits, and total costs peaked 1-year pre- and post-identification.
- These data coupled with recommendations for annual screening for cognitive impairment in PD support the early diagnosis and management of cognitive impairment in order to optimize care for patients and their caregivers.
Why it matters
This study describes characteristics of patients with Parkinson's disease who were newly diagnosed with cognitive impairment, including more hospitalizations and higher healthcare costs. It does not test any treatment, cure, or prevention for Alzheimer's disease, and it supports early diagnosis and management of cognitive impairment in Parkinson's disease.
Study details
- Participants2,711
- Effect sizeOR = 1.60; OR = 1.36; OR = 1.24
- Evidence strengthLow
How this study scored 49/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Parkinson s Disease) |
| Journal's citation record | 1 / 4 | Journal of Parkinson s Disease: journal h-index 97 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2021 — within 6 year(s) of the newest study here |
| Sample size | 3 / 4 | 2,711 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 28 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.0 citations a year over 7 year(s) since 2021 |
| Impact for its field and year | 2 / 6 | Cited 1.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 2 / 4 | Cited 18 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Nick C. Patel: h-index 31 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Eli Lilly (United States): institution h-index 744 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 33720850) |
| Free to read | 2 / 2 | Free to read |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3233/jpd-202190
- PubMed: 33720850
- Original source →
- Free full text: Journal of Parkinson s Disease →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Health systems and care delivery from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.